Neurologian yksikkö
Department of Neurology

Julkaisut 2004
Publications 2004

Lisätietoja julkaisusta saa klikkaamalla sen numeroa.
For full details, please click the number in front of the publication.

1 Winblad B et al. Mild cognitive impairment - beyond controversies, towards a consensus: report ot the international working group on mild cognitive impairment.
2 Ajamian F et al. Selective regulation of class I and class II histone deacetylases expression by inhibitors of histone deacetylases in cultured mouse neural cells.
3 Antikainen R et al. A decrease in memory complaints in associated with mood improvement: A twelve-month follow up-study of depressed patients.
4 Anttila T et al. Alcohol drinking in middle age and subsequent risk of mild cognitive impairment and dementia in old age: a prospective population based study.
5 Autere J et al. Mitochondrial DNA polymorphisms as risk factors for Parkinson´s disease and Parkinson´s disease dementia.
6 Boccardi M et al. APOE and modulation of Alzheimer´s and frontotemporal dementia.
7 Bonetti A et al. A two-stage study on multiple sclerosis susceptibility and chromosome 2q33.
8 Brainin M et al. Organization of stroke care: education, referral, emergency management and imaging, stroke units and rehabilitation.
9 Bunce D et al. Utilization of cognitive support in episidic free recall as a function of apolipoprotein E and vitamin B12 or folate among adults aged 75 years and older.
10 Diener H-C et al. Management of atherothrombosis with clopidogrel in high-risk patients with recent transient ischaemic attack of ischaemic stroke (MATCH): Study design and baseline data.
11 Diener H-C et al. Aspirin and clopidogrel compared with clopidogrel alone after recent ischaemic stroke or transient ischaemic attack in high-risk patients (MATCH): randomised, double-blind, placebo-controlled trial.
12 Faisel F et al. Susceptibility to pre-eclampsia in Finnish women is associated with R485K polymorphism in the factor V gene, not with Leiden mutation.
13 Friedlich AL et al. Neuronal zinc exhange with the blood vessel wall promotes cerebral amyloid angiopathy in an animal model of Alzheimer´s disease.
14 Gureviciene I et al. Normal induction by accelerated decay of LTP in APP + PS1 transgenic mice.
15 Gurevicius K et al. Enhanced cortical and hippocampal neuronal excitability in mice deficient in the extracellular matrix glycoprotein tenascin-R.
16 Heikkinen T et al. Estrogen treatment improves spatial learning in APP + PS1 mice but does not affect beta amyloid accumulation and plaque formation.
17 Heikkinen T et al. Effects of long-term ovariectomy and estrogen treatment on maze learning in aged mice.
18 Heinonen S et al. The 121Q allele of the plasma cell membrane glycoprotein 1 gene predisposes to polycystic ovary syndrome.
19 Helisalmi S et al. Possible association of nicastrin polymorphisms and Alzheimer disease in the Finnish population.
20 Helisalmi S et al. Genetic variation in apolipoprotein D and Alzheimer´s disease.
21 Helisalmi S et al. Polymorphisms in neprilysin gene affect the risk of Alzheimer´s disease in Finnish patients.
22 Hiltunen M et al. Alzheimerin taudin genetiikka.
23 Huuskonen J et al. Regulation of microglial inflammatory response by sodium butyrate and short-chain fatty acids.
24 Hänninen T, Pulliainen V. Kognitiivisten häiriöiden seulonta.
25 Hänninen T, Soininen H. Muistihäiriöt ja dementia.
26 Ihalainen JA, Tanila H. In vivo regulation of dopamine and noradrenaline release by alpha2A-adrenoceptors in the mouse nucleus accumbens.
27 Iivonen S et al. Polymorphisms in the CYP19 gene confer increased risk for Alzheimer disease.
28 Immonen A et al. Preoperative clinical evaluation, outline of surgical technique and outcome in termporal lobe epilepsy.
29 Jakovljevic D, on behalf of the FINSTROKE Register Group. Day of the week and ischemic stroke - Is it monday high or sunday low?
30 Jones RW et al. A multinational, randomised, 12-week study comparing the effects of donepezil and galantamine in patients with mild to moderate Alzheimer´s disease.
31 Joyal CC et al. MRI volumetry of the vermis and cerebellar hemispheres in men with schizophrenia.
32 Järvenpää T et al. Hippocampal MRI volumetry in congenitively discordant monozygotic twin pairs.
33 Jääskeläinen E et al. M385T polymorphism in the factor V gene, but not leiden mutation, is associated with placental abruption in finnish women.
34 Kaasinen SK et al. Spermidine/spermine N1-acetyltransferase overexpression in mice induces hypoactivity and spatial learning impairment.
35 Kalesnykas G et al. Cholinergic neurons in the basal forebrain of aged female mice.
36 Kanninen K et al. Glycosylation changes in Alzheimer's disease as revealed by a proteomic approach.
37 Kerokoski P et al. Both N-methyl-D-aspartate (NMDA) and non-NMDA receptors mediate glutamate-induced cleavage of the cyclin-dependent kinase 5 (cdk5) activator p35 in cultured rat hippocampal neurons.
38 Kuusisto E. Role of the p62 Protein in the Formation of Neuropathological Cytoplasmic Inclusions.
39 Lane RM et al. Acetylcholinesterase and its inhibition in Alzheimer Disease.
40 Lehtonen A et al. Declining incidence and mortality of stroke in persons aged > or = 75 years in Finland; the FINSTROKE study.
41 Leys D et al. Prevention.
42 Li X et al. Phosphorylated eukaryotic translation factor 4E is elevated in alzheimer brain.
43 Liu L et al. Longitudinal observation on CSF Abeta42 levels in young to middle-aged amyloid precursor protein/presenilin-1 doubly transgenic mice.
44 Martikainen J et al. Potential cost-effectiveness of a family based program in mild Alzheimer´s disease patients.
45 Minkeviciene R et al. Memantine improves spatial learning in a transgenic mouse model of Alzheimer´s disease.
46 Pennanen C et al. Hippocampus and entorhinal cortex in mild cognitive impairment and early AD.
47 Pennanen C et al. Serum testosterone levels in males with Alzheimer´s disease.
48 Peurala SH et al. How much exercise does the enhanced gait-oriented physiotherapy provide for chronic stroke patients?
49 Pihlajamäki M. Functional MRI Studies on Human Declarative Memory.
50 Pihlajamäki M et al. Visual presentation of novel objects and new spatial arrangements of objects differentially activates the medial temporal lobe subareas in humans.
51 Pirttilä T. Varhainen MS-tauti - diagnostinen haaste.
52 Pirttilä T. Taudin kulkua muunteleva hoito MS-taudissa.
53 Pirttilä T, Nybo T. Kipu ja kognitio.
54 Pirttilä T. Muistihäiriöisen ja dementoituvan henkilön kuntoutus: Muistihäiriöisen ja dementoituvan henkilön kuntoutuksen mahdollisuudet.
55 Pirttilä T. Mitä kaikkea minun pitäisi tietää dementiasta?
56 Pirttilä T. Dementia.
57 Pirttilä T et al. Voidaanko muistin heikentymistä ehkäistä?
58 Pirttilä T et al. Cerebrospinal fluid insulin-like growth factor-1, insulin growth factor binding protein-2 or nitric oxide are not increased in MS or ALS.
59 Pirttilä T et al. Long-term efficacy and safety of galantamine in patients with mild-to-moderate Alzheimer´s disease: multicenter trial.
60 Puurunen K et al. Neuroprotection by the alfa2-adrenoceptor agonist, dexmedetomidine, in experimental stroke models.
61 Qiu C et al. Risk and protective effects of the APOE gene towards Alzheimer´s disease in the Kungsholmen project: variation by age and sex.
62 Raitanen T et al. Geropsykologia. Vanhenemisen ja vanhuuden psykologia.
63 Sivenius J, Jolkkonen J. Uutta näyttöä aivohalvauskuntoutuksen vaikutuksista.
64 Sivenius J et al. Continuous 15-year decrease in incidence and mortality of stroke in Finland. The FINSTROKE Study.
65 Sivenius J et al. FINSTROKE-tutkimus: Aivohalvauksen ilmaantuvuus ja kuolleisuus laskivat Suomessa vuosina 1983-1997.
66 Suomen Kehitysvammalääkärit ry:n asettama työryhmä. Downin oireyhtymään liittyvien lääketieteellisten ongelmien hyvä hoito. Käypä hoito -suositus.
67 Taipale P et al. Prenatal diagnosis of placenta accreta and percreta with ultarasonography, color doppler and magnetic resonance imaging.
68 Tervo AJ et al. An in silico approach to discovering novel inhibitors of human sirtuin type 2.
69 Tervo S et al. Incidence and risk factors for mild cognitive impairment: a population-based three-year follow-up study of cognitively healthy elderly subjects.
70 Testa C et al. A comparison between the accurancy of voxel-based morphometry and hippocampal volumetry in Alzheimer`s disease.
71 Toivonen S et al. Low-activity haplotype of the microsomal epoxide hydrolase gene is protective against placental abruption.
72 van Groen T et al. Retrosplenial cortex lesions of area Rgb (but not of area Rga) impair spatial learning and memory in the rat.
73 Virtanen T et al. Re: External carotid artery territory ischemia impairs outcome in the endovascular filament model of middle cerebral artery occlusion in rats.
74 Väisänen J et al. Effects of NMDA-receptor antagonist treatment on c-fos expression in rat brain areas implicated in schizophrenia.
75 Wilson IA et al. Cognitive aging and the hippocampus: How old rats represent new environments.
76 Wolf H et al. Serum lipids and hippocampal volume: the link to Alzheimer´s disease?
77 Yavich L et al. Role of alfa-synuclein in presynaptic dopamine recruitment .

Neurologian yksikkö Department of Neurology
Julkaisutietokanta 15.4.2008 Publications Data Base 15.4.2008